GlassScriptPhysician profile
Alison Marie Thomas
NPI 1982224838
$2,315.35
in general payments reported to CMS, 2019-2025
20 companies · $1,801 in 2025
The $1,801 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.07 · 2023: $179 · 2024: $320 · 2025: $1,801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,173 · Travel and Lodging: $1,029 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.53 |
| Travel and Lodging | $1,028.75 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,221.25 | 2025 | Harmonic |
| Astellas Pharma US INC | $258.89 | 2024-2025 | Veozah |
| Ethicon US, LLC | $168.80 | 2023-2025 | Enseal, Harmonic, Surgicel Nu-Knit |
| Gynesonics, INC. | $150.66 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $80.08 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Coolseal Generator, Acessa Provu System |
| Sage Therapeutics, LLC | $52.32 | 2025 | Zurzuvae |
| Organon LLC | $48.46 | 2024-2025 | Nexplanon |
| Glaxosmithkline, LLC. | $44.41 | 2021-2025 | Trelegy Ellipta |
| Coopersurgical, INC. | $35.63 | 2024-2025 | Paragard T 380a |
| Axonics, INC. | $34.73 | 2024 | Axonics |
| Exeltis, USA INC. | $31.91 | 2025 | Slynd |
| Mayne Pharma Commercial LLC | $29.38 | 2025 | |
| Dexcom, INC. | $26.52 | 2025 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $24.96 | 2025 | Injectafer |
| Mimedx Group, INC. | $22.60 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.11 | 2025 | Pico 7 |
| Channel Medsystems, INC. | $18.17 | 2025 | |
| Shield Therapeutics INC | $15.90 | 2025 | |
| Aspira Women'S Health INC | $15.10 | 2024 | Ova1 |
| Sumitomo Pharma America, INC. | $14.47 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.